Market revenue in 2023 | USD 5.1 million |
Market revenue in 2030 | USD 7.9 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | Cardiac |
Fastest growing segment | Dermatology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiac, Dermatology, Nasal |
Key market players worldwide | Medtronic PLC, Becton Dickinson & Co, Edwards Lifesciences Corp, LivaNova PLC, Smiths Group PLC, Boston Scientific Corp |
Cardiac was the largest segment with a revenue share of 47.06% in 2023. Horizon Databook has segmented the Mexico cannula market based on cardiac, dermatology, nasal covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in expenditure on improving healthcare infrastructure is anticipated to boost the market. Increase in life expectancy is leading to a rise in demand for medical devices. Presence of a large number of hospitals in the country is expected to fuel the market growth during the forecast period. As of 2013, Mexico had more than 4,466 hospitals, of these, 67.0% were private and remaining 33.0% were government. In addition, Mexico is one of the major hubs of export of medical devices to the U.S. and European countries, which provides lucrative opportunities to cannula market players.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account